{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"HealthTech Remedy","title":"Amy Abernethy: Real-World Data & Streamlining Clinical Research","html":"","width":"100%","height":180,"duration":2378,"description":"How can a brilliant oncologist, computer scientist, and former top FDA official fix the slow, broken, and expensive system of clinical trials? In this episode, we sit down with Dr. Amy Abernethy, a true physician innovator, to uncover the critical need for streamlining clinical research with real-world data. Dr. Abernethy has spent her career tackling one of healthcare’s biggest challenges: how to get effective treatments to the patients who need them, faster. From pioneering research at Duke to scaling a startup to a multi-billion dollar acquisition and modernizing the FDA’s entire data infrastructure, she reveals the playbook for building a true learning health system.In this deep-dive conversation, Dr. Amy Abernethy shares her incredible physician innovator career path, which took her from the clinic at Duke University to executive roles at Flatiron Health, the FDA, Verily, and now as the co-founder of Highlander Health. She begins by detailing her early academic work building a \"Center for Learning Healthcare,\" where she focused on using patient-reported outcomes and electronic data to understand what treatments truly work. However, she hit a ceiling in academia, realizing that the grant-based model couldn't scale. This led to her pivot to industry and Flatiron Health, where she shares invaluable lessons on scaling health tech companies. Dr. Abernethy discusses the importance of creating a common language (\"lingua franca\") between clinicians, engineers, and product teams, and establishing a North Star through shared corporate values.This experience was crucial for her next chapter at the U.S. Food and Drug Administration, where she served as Principal Deputy Commissioner. Dr. Abernethy provides a rare insider's look at the immense challenges and surprising speed of government work, particularly her focus on FDA data modernization. She explains how the looming wave of cell and gene therapies and the EVALI vaping crisis created an urgent need for a...","thumbnail_url":"https://img.transistorcdn.com/Al9s4QJpRCg2VJ2YaV_fo3tDCayXbUO7NTDbnFeSAUQ/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNTVk/OTAwMzQxYWFiZmYy/ZWFlNzFmN2RmOTcx/MDMwNy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}